Lonza Group AG (OTCMKTS:LZAGY) Short Interest Update

Lonza Group AG (OTCMKTS:LZAGY) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 52,400 shares, an increase of 4,663.6% from the May 31st total of 1,100 shares. Based on an average daily volume of 71,700 shares, the short-interest ratio is presently 0.7 days.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank upgraded shares of Lonza Group to a “strong-buy” rating in a research note on Sunday, June 23rd.

Lonza Group Stock Up 0.5 %

LZAGY stock traded up $0.27 during midday trading on Friday, hitting $54.50. The company’s stock had a trading volume of 15,138 shares, compared to its average volume of 35,147. The firm’s 50-day moving average is $55.74 and its 200-day moving average is $51.89. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.20 and a current ratio of 1.77. Lonza Group has a 12 month low of $34.19 and a 12 month high of $64.88.

Lonza Group Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, May 29th. Stockholders of record on Thursday, May 16th were issued a dividend of $0.0995 per share. The ex-dividend date of this dividend was Wednesday, May 15th.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.